Prevention of primary tumor growth and suppression of metastasis with continuous, low-dose treatment with the angiogenic inhibitor, NORLEUAL, in a mouse model of breast cancer.

被引：0
|
作者：
Masino, JA [1 ]
Yamamoto, B [1 ]
Zornes, P [1 ]
Harding, JW [1 ]
机构：
[1] Washington State Univ, Pullman, WA 99164 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2003年 / 12卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1288S / 1289S
页数：2
相关论文
共 50 条
  • [21] Rebastinib, a small molecule TIE2 kinase inhibitor, prevents primary tumor growth and lung metastasis in the PyMT breast cancer model
    Smith, Bryan D.
    Hood, Molly M.
    Kaufman, Michael D.
    Berger, Mark
    Flynn, Daniel L.
    Wise, Scott C.
    CANCER RESEARCH, 2013, 73
  • [22] Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models
    Azuma, H
    Takahara, S
    Ichimaru, N
    Wang, JD
    Itoh, Y
    Otsuki, Y
    Morimoto, J
    Fukui, R
    Hoshiga, M
    Ishihara, T
    Nonomura, N
    Suzuki, S
    Okuyama, A
    Katsuoka, Y
    CANCER RESEARCH, 2002, 62 (05) : 1410 - 1419
  • [23] Effect of low-dose, short-course sunitinib (Su) on tumor vasculature and tumor blood flow for enhancement of chemotherapy efficacy in breast cancer.
    Wong, Andrea Li Ann
    Sundar, Raghav
    Ow, Samuel Guan Wei
    Wang, Ting Ting
    Ng, Thian-C
    Chan, Ching-Wan
    Hartman, Mikael
    Lau, Philip
    Tan, Sing Huang
    Zhang, Bo
    Thng, Choon Hua
    Mogro, Maria Jannet
    Voon, Pei Jye
    Buhari, Shaik Ahmad
    Soh, I. Peng Thomas
    Goh, Boon C.
    Lee, Soo-Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Oral Recombinant Methioninase Sensitizes a Bladder Cancer Orthotopic Xenograft Mouse Model to Low-dose Cisplatinum and Prevents Metastasis
    Sun, Yu
    Nishino, Hiroto
    Sugisawa, Norihiko
    Yamamoto, Jun
    Hamada, Kazuyuki
    Zhu, Guangwei
    Lim, Hye In
    Hoffman, Robert M.
    ANTICANCER RESEARCH, 2020, 40 (11) : 6083 - 6091
  • [25] Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UKI
    Setyono-Han, B
    Stürzebecher, J
    Schmalix, WA
    Muehlenweg, B
    Sieuwerts, AM
    Timmermans, M
    Magdolen, V
    Schmitt, M
    Klijn, JGM
    Foekens, JA
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (04) : 779 - 786
  • [26] The RANKL inhibitor osteoprotegerin (OPG) inhibits tumor growth, prevents tumor-induced osteolysis, and significantly improves survival in a mouse model of breast cancer bone metastasis
    Canon, J.
    Roudier, M.
    Bryant, R.
    Radinsky, R.
    Dougall, W.
    EJC SUPPLEMENTS, 2006, 4 (12): : 166 - 167
  • [27] Low-dose salinomycin inhibits breast cancer metastasis by repolarizing tumor hijacked macrophages toward the M1 phenotype
    Shen, Huan
    Sun, Changquan Calvin
    Kang, Lichun
    Tan, Xiaoyue
    Shi, Peng
    Wang, Lingyu
    Liu, Ergang
    Gong, Junbo
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 157
  • [28] Expression of maspin by human breast tumor cells inhibits primary tumor cell growth and lung metastasis in an athymic mouse model.
    Ding, I
    Huang, HD
    Sabet, H
    Zou, ZO
    Zhang, LR
    Kern, FG
    Okunieff, P
    BLOOD, 1996, 88 (10) : 3917 - 3917
  • [29] SKI-606, an Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid Cancer
    Kim, Won Gu
    Guigon, Celine J.
    Fozzatti, Laura
    Park, Jeong Won
    Lu, Changxue
    Willingham, Mark C.
    Cheng, Sheue-yann
    CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1281 - 1290
  • [30] Low-dose heparin treatment does not inhibit SW480 human colon cancer growth and metastasis in vivo
    Antachopoulos, CT
    Gagos, S
    Iliopoulos, DC
    Karayannacos, PE
    TseleniBalafouta, S
    Alevras, P
    Koundouris, C
    Skalkeas, GD
    IN VIVO, 1996, 10 (05): : 527 - 531
12345